These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 18991629)

  • 1. A review of coumarin derivatives in pharmacotherapy of breast cancer.
    Musa MA; Cooperwood JS; Khan MO
    Curr Med Chem; 2008; 15(26):2664-79. PubMed ID: 18991629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicinal chemistry aspects and synthetic strategies of coumarin as aromatase inhibitors: an overview.
    Ratre P; Kulkarni S; Das S; Liang C; Mishra PK; Thareja S
    Med Oncol; 2022 Dec; 40(1):41. PubMed ID: 36471176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor agonists/antagonists in breast cancer therapy: A critical review.
    Jameera Begam A; Jubie S; Nanjan MJ
    Bioorg Chem; 2017 Apr; 71():257-274. PubMed ID: 28274582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review on Pharmacological Properties of Coumarins.
    Srikrishna D; Godugu C; Dubey PK
    Mini Rev Med Chem; 2018; 18(2):113-141. PubMed ID: 27488585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-breast Cancer Potential of Natural and Synthetic Coumarin Derivatives.
    Song F; Huo X; Guo Z
    Curr Top Med Chem; 2021; 21(18):1692-1709. PubMed ID: 33655862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and biological characterization of a novel anti-aromatase coumarin derivative.
    Chen S; Cho M; Karlsberg K; Zhou D; Yuan YC
    J Biol Chem; 2004 Nov; 279(46):48071-8. PubMed ID: 15358790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents.
    Keri RS; Sasidhar BS; Nagaraja BM; Santos MA
    Eur J Med Chem; 2015 Jul; 100():257-69. PubMed ID: 26112067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coumarin Hybrids: Promising Scaffolds in the Treatment of Breast Cancer.
    Bhatia R; Rawal RK
    Mini Rev Med Chem; 2019; 19(17):1443-1458. PubMed ID: 30854961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coumarin-Fatty Acid Conjugates as Potential ERα/AKT-1 Antagonists for ER Positive Breast Cancer.
    Selvaraj J; John JBA; Joghee NM; Antony J; Wadhwani A; Natarajan J
    Anticancer Agents Med Chem; 2020; 20(4):437-449. PubMed ID: 31746305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicinal applications of coumarins bearing azetidinone and thiazolidinone moieties.
    Patil SA; Patil SA; Fariyike T; Marichev KO; Heras Martinez HM; Bugarin A
    Future Med Chem; 2021 Nov; 13(21):1907-1934. PubMed ID: 34468216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review on Coumarin Derivatives as Potent Anti-tuberculosis Agents.
    Mujeeb S; Singh K; Yogi B; Ansari V; Sinha S
    Mini Rev Med Chem; 2022; 22(7):1064-1080. PubMed ID: 34579635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of fluorinated N-benzoyl and N-phenylacetoyl derivatives of 3-(4-aminophenyl)-coumarin-7-O-sulfamate as steroid sulfatase inhibitors.
    Daśko M; Przybyłowska M; Rachon J; Masłyk M; Kubiński K; Misiak M; Składanowski A; Demkowicz S
    Eur J Med Chem; 2017 Mar; 128():79-87. PubMed ID: 28152429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer mechanism of coumarin-based derivatives.
    Yadav AK; Maharjan Shrestha R; Yadav PN
    Eur J Med Chem; 2024 Mar; 267():116179. PubMed ID: 38340509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational role of natural coumarins and their derivatives as anticancer agents.
    Menezes JC; Diederich M
    Future Med Chem; 2019 May; 11(9):1057-1082. PubMed ID: 31140865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current developments of coumarin-based anti-cancer agents in medicinal chemistry.
    Emami S; Dadashpour S
    Eur J Med Chem; 2015 Sep; 102():611-30. PubMed ID: 26318068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The current landscape of coumarin hybrids with antibreast cancer therapeutic applications: An updated review.
    Wang R; Chen Z; Huang Y; Zhang Q; Chen M; Huang X
    Arch Pharm (Weinheim); 2024 Oct; 357(10):e2400438. PubMed ID: 38982307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates.
    Woo LL; Purohit A; Malini B; Reed MJ; Potter BV
    Chem Biol; 2000 Oct; 7(10):773-91. PubMed ID: 11033081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review on Chemical Profile of Coumarins and their Therapeutic Role in the Treatment of Cancer.
    Venkata Sairam K; Gurupadayya BM; Chandan RS; Nagesha DK; Vishwanathan B
    Curr Drug Deliv; 2016; 13(2):186-201. PubMed ID: 26135671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic and natural coumarins as potent anticonvulsant agents: A review with structure-activity relationship.
    Keri RS; Budagumpi S; Balappa Somappa S
    J Clin Pharm Ther; 2022 Jul; 47(7):915-931. PubMed ID: 35288962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human estrogen receptor α antagonists, part 2: Synthesis driven by rational design, in vitro antiproliferative, and in vivo anticancer evaluation of innovative coumarin-related antiestrogens as breast cancer suppressants.
    Kurtanović N; Tomašević N; Matić S; Mitrović MM; Kostić DA; Sabatino M; Antonini L; Ragno R; Mladenović M
    Eur J Med Chem; 2022 Jan; 227():113869. PubMed ID: 34710747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.